These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23754313)

  • 1. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.
    Unruh D; Turner K; Srinivasan R; Kocatürk B; Qi X; Chu Z; Aronow BJ; Plas DR; Gallo CA; Kalthoff H; Kirchhofer D; Ruf W; Ahmad SA; Lucas FV; Versteeg HH; Bogdanov VY
    Int J Cancer; 2014 Jan; 134(1):9-20. PubMed ID: 23754313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.
    Unruh D; Ünlü B; Lewis CS; Qi X; Chu Z; Sturm R; Keil R; Ahmad SA; Sovershaev T; Adam M; Van Dreden P; Woodhams BJ; Ramchandani D; Weber GF; Rak JW; Wolberg AS; Mackman N; Versteeg HH; Bogdanov VY
    Oncotarget; 2016 May; 7(18):25264-75. PubMed ID: 26967388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma.
    Lewis CS; Backman C; Ahsan S; Cliff A; Hariharan A; Yeh JJ; Zhang X; Xie C; Sohal DPS; Bogdanov VY
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions.
    Ramchandani D; Unruh D; Lewis CS; Bogdanov VY; Weber GF
    Lab Invest; 2016 Dec; 96(12):1234-1245. PubMed ID: 27721473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.
    Unruh D; Sagin F; Adam M; Van Dreden P; Woodhams BJ; Hart K; Lindsell CJ; Ahmad SA; Bogdanov VY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1206-11. PubMed ID: 25963480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.
    Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH
    J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.
    Signaevsky M; Hobbs J; Doll J; Liu N; Soff GA
    Semin Thromb Hemost; 2008 Mar; 34(2):161-9. PubMed ID: 18645921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?
    van den Berg YW; Versteeg HH
    Hamostaseologie; 2010 Aug; 30(3):144-9. PubMed ID: 20680231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
    Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.
    Giannarelli C; Alique M; Rodriguez DT; Yang DK; Jeong D; Calcagno C; Hutter R; Millon A; Kovacic JC; Weber T; Faries PL; Soff GA; Fayad ZA; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2014 Oct; 130(15):1274-86. PubMed ID: 25116956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatively spliced tissue factor induces angiogenesis through integrin ligation.
    van den Berg YW; van den Hengel LG; Myers HR; Ayachi O; Jordanova E; Ruf W; Spek CA; Reitsma PH; Bogdanov VY; Versteeg HH
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19497-502. PubMed ID: 19875693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPC impedes m
    Huang XT; Li JH; Zhu XX; Huang CS; Gao ZX; Xu QC; Zhao W; Yin XY
    Cancer Lett; 2021 Oct; 518():196-206. PubMed ID: 34271104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.